BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 34174909)

  • 1. Pharmacological rescue of cognitive function in a mouse model of chemobrain.
    Nguyen LD; Fischer TT; Ehrlich BE
    Mol Neurodegener; 2021 Jun; 16(1):41. PubMed ID: 34174909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention of paclitaxel-induced peripheral neuropathy by lithium pretreatment.
    Mo M; Erdelyi I; Szigeti-Buck K; Benbow JH; Ehrlich BE
    FASEB J; 2012 Nov; 26(11):4696-709. PubMed ID: 22889832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lithium attenuates peripheral neuropathy induced by paclitaxel in rats.
    Pourmohammadi N; Alimoradi H; Mehr SE; Hassanzadeh G; Hadian MR; Sharifzadeh M; Bakhtiarian A; Dehpour AR
    Basic Clin Pharmacol Toxicol; 2012 Mar; 110(3):231-7. PubMed ID: 21917116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRPV4 inhibition prevents paclitaxel-induced neurotoxicity in preclinical models.
    Boehmerle W; Huehnchen P; Lee SLL; Harms C; Endres M
    Exp Neurol; 2018 Aug; 306():64-75. PubMed ID: 29715474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Accelerated cerebromicrovascular senescence contributes to cognitive decline in a mouse model of paclitaxel (Taxol)-induced chemobrain.
    Ahire C; Nyul-Toth A; DelFavero J; Gulej R; Faakye JA; Tarantini S; Kiss T; Kuan-Celarier A; Balasubramanian P; Ungvari A; Tarantini A; Nagaraja R; Yan F; Tang Q; Mukli P; Csipo T; Yabluchanskiy A; Campisi J; Ungvari Z; Csiszar A
    Aging Cell; 2023 Jul; 22(7):e13832. PubMed ID: 37243381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental Ethanol-Induced Sleep Fragmentation, Behavioral Hyperactivity, Cognitive Impairment and Parvalbumin Cell Loss are Prevented by Lithium Co-treatment.
    Lewin M; Ilina M; Betz J; Masiello K; Hui M; Wilson DA; Saito M
    Neuroscience; 2018 Jan; 369():269-277. PubMed ID: 29183826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of GABA
    Li Z; Liu P; Zhang H; Zhao S; Jin Z; Li R; Guo Y; Wang X
    Pharm Biol; 2017 Dec; 55(1):2188-2195. PubMed ID: 29115173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neuroprotective effect of lithium chloride on cognitive impairment through glycogen synthase kinase-3β inhibition in intracerebral hemorrhage rats.
    Liu Z; Li R; Jiang C; Zhao S; Li W; Tang X
    Eur J Pharmacol; 2018 Dec; 840():50-59. PubMed ID: 30336136
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nasal administration of mitochondria reverses chemotherapy-induced cognitive deficits.
    Alexander JF; Seua AV; Arroyo LD; Ray PR; Wangzhou A; Heiβ-Lückemann L; Schedlowski M; Price TJ; Kavelaars A; Heijnen CJ
    Theranostics; 2021; 11(7):3109-3130. PubMed ID: 33537077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bexarotene normalizes chemotherapy-induced myelin decompaction and reverses cognitive and sensorimotor deficits in mice.
    Chiang ACA; Seua AV; Singhmar P; Arroyo LD; Mahalingam R; Hu J; Kavelaars A; Heijnen CJ
    Acta Neuropathol Commun; 2020 Nov; 8(1):193. PubMed ID: 33183353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin mitigates cisplatin-induced cognitive impairment in rats and improves hippocampal dendritic spine density.
    Qutifan S; Saleh T; Abu Shahin N; ELBeltagy M; Obeidat F; Qattan D; Kalbouneh H; Barakat NA; Alsalem M
    Neuroreport; 2024 Jul; 35(10):657-663. PubMed ID: 38813907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gamma entrainment using audiovisual stimuli alleviates chemobrain pathology and cognitive impairment induced by chemotherapy in mice.
    Kim T; James BT; Kahn MC; Blanco-Duque C; Abdurrob F; Islam MR; Lavoie NS; Kellis M; Tsai LH
    Sci Transl Med; 2024 Mar; 16(737):eadf4601. PubMed ID: 38446899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caffeic acid phenethyl ester counteracts doxorubicin-induced chemobrain in Sprague-Dawley rats: Emphasis on the modulation of oxidative stress and neuroinflammation.
    Ali MA; Menze ET; Tadros MG; Tolba MF
    Neuropharmacology; 2020 Dec; 181():108334. PubMed ID: 33011199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel Reduces Axonal Bclw to Initiate IP
    Pease-Raissi SE; Pazyra-Murphy MF; Li Y; Wachter F; Fukuda Y; Fenstermacher SJ; Barclay LA; Bird GH; Walensky LD; Segal RA
    Neuron; 2017 Oct; 96(2):373-386.e6. PubMed ID: 29024661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pifithrin-μ Prevents Cisplatin-Induced Chemobrain by Preserving Neuronal Mitochondrial Function.
    Chiu GS; Maj MA; Rizvi S; Dantzer R; Vichaya EG; Laumet G; Kavelaars A; Heijnen CJ
    Cancer Res; 2017 Feb; 77(3):742-752. PubMed ID: 27879267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium prevents long-term neural and behavioral pathology induced by early alcohol exposure.
    Sadrian B; Subbanna S; Wilson DA; Basavarajappa BS; Saito M
    Neuroscience; 2012 Mar; 206():122-35. PubMed ID: 22266347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium chloride administration prevents spatial learning and memory impairment in repeated cerebral ischemia-reperfusion mice by depressing apoptosis and increasing BDNF expression in hippocampus.
    Fan M; Jin W; Zhao H; Xiao Y; Jia Y; Yin Y; Jiang X; Xu J; Meng N; Lv P
    Behav Brain Res; 2015 Sep; 291():399-406. PubMed ID: 26031381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rationale and design of the prevention of paclitaxel-related neurological side effects with lithium trial - Protocol of a multicenter, randomized, double-blind, placebo- controlled proof-of-concept phase-2 clinical trial.
    Huehnchen P; Bangemann N; Lischewski S; Märschenz S; Paul F; Schmitz-Hübsch T; Blohmer JU; Eberhardt C; Rauch G; Flöel A; Adam S; Schwenkenbecher P; Meinhold-Heerlein I; Hoffmann O; Ziemssen T; Endres M; Boehmerle W
    Front Med (Lausanne); 2022; 9():967964. PubMed ID: 36035422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LiCl Pretreatment Ameliorates Adolescent Methamphetamine Exposure-Induced Long-Term Alterations in Behavior and Hippocampal Ultrastructure in Adulthood in Mice.
    Yan P; Xu D; Ji Y; Yin F; Cui J; Su R; Wang Y; Zhu Y; Wei S; Lai J
    Int J Neuropsychopharmacol; 2019 Apr; 22(4):303-316. PubMed ID: 30649326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating Image-Based High-Content Screening with Mouse Models Identifies 5-Hydroxydecanoate as a Neuroprotective Drug for Paclitaxel-Induced Neuropathy.
    Chen LH; Sun YT; Chen YF; Lee MY; Chang LY; Chang JY; Shen MR
    Mol Cancer Ther; 2015 Oct; 14(10):2206-14. PubMed ID: 26294744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.